Akorn Inc (AKRX) 22.81 $AKRX
Actavis to Acquire Four Products from Akorn
PR Newswire - Thu Apr 17, 3:15PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has entered into agreements with Akorn, Inc. and Hi-Tech Pharmacal Co. Inc. to purchase four currently marketed products and one product under development for cash consideration. The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech. Financial terms of the agreements were not disclosed.
Akorn Completes Acquisition of Hi-Tech Pharmacal
Business Wire - Thu Apr 17, 8:20AM CDT
Akorn, Inc. (NASDAQ: AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) for $640 million in cash. The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player. This combination also brings critical mass and scale to Akorn's business and strengthens the Company's position with retail and institutional customers.
Repligen Corporation Set to Join the S&P SmallCap 600
PR Newswire - Tue Apr 15, 4:53PM CDT
Repligen Corporation (NASD:RGEN) will replace Hi-Tech Pharmacal Co., Inc. (NASD:HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. S&P SmallCap 600 constituent Akorn Inc. (NASD:AKRX) is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.
Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition
Business Wire - Mon Apr 14, 6:00PM CDT
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn's acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK). The unanimous vote in support of the transactions follows Akorn's agreement to a proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval. The parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by the end of this week.
Akorn, Inc. Announces First Quarter 2014 Earnings Release and Conference Call Information
PR Newswire - Thu Apr 10, 3:00PM CDT
Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, May 6, 2014, to discuss first quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Insider Trading Alert - BRCD, AKRX And CSOD Traded By Insiders
at The Street - Thu Mar 20, 10:00AM CDT
Stocks with insider trader activity include BRCD, AKRX and CSOD
Approvals, Financial Results, and Stock Movements - Analyst Notes on Merck, Novartis, Raptor, Akorn, and Pacira
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Novartis AG (NYSE: NVS), Raptor Pharmaceutical Corp. (NASDAQ: RPTP), Akorn, Inc. (NASDAQ: AKRX), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Stocks on the Radar: Akorn, Central European Media Enterprises, Denny's, bebe stores, and Eni SpA
PR Newswire - Tue Mar 04, 9:25AM CST
The US markets ended on a negative sentiment on Monday, March 03, 2014, with the NASDAQ Composite closing at 4,277.30, down 0.72%; the Dow Jones Industrial Average ending the session at 16,168.03, down 0.94%, and S&P 500 edging 0.74% lower to close at 1,845.73. The losses were broad based with all ten sectors edging lower. Investor-Edge.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Central European Media Enterprises Ltd (NASDAQ: CETV), Denny's Corp. (NASDAQ: DENN), bebe stores inc. (NASDAQ: BEBE), and Eni SpA (NYSE: E) which witnessed unusually high trading volumes in the previous trading session. Free report on these five companies can be accessed at
Harwood Feffer LLP Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 8:00PM CST
NEW YORK, March 3, 2014 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against Akorn, Inc. ("Akorn" or the "Company"
(NASDAQ: AKRX) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.
Akorn's guidance disappoints
at Investor's Business Daily - Mon Mar 03, 5:36PM CST
The specialty drug maker's Q4 EPS rose 7.7% to 14 cents, in line with views. Sales rose 19% to $85 mil, above analysts' estimates for $83 mil. For all '13, sales rose 24% to $318 mil and net income climbed 6% to 55 cents a share. It guided '14 sales...
Akorn Guidance Worries Street As Strategy Hits Delays
at Investor's Business Daily - Mon Mar 03, 4:30PM CST
Specialty drugmaker Akorn's Q4 earnings met estimates Monday, but its 2014 guidance and a new accounting problem halted the IBD 50 stock dead in its tracks. Akorn (AKRX) said profit totaled 14 cents a share, up a penny from the year-earlier quarter...
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 3:52PM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Akorn, Inc. ("Akorn" or the "Company" (NasdaqGS: AKRX). Such investors are advised to contact Peretz Bronstein or his investor Relation's coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 03, 12:34PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Why Akorn, Inc. Shares Were Cracked
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 12:22PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Akorn , a branded and generic developer of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX
PR Newswire - Mon Mar 03, 12:07PM CST
Pomerantz LLP is investigating claims on behalf of investors of Akorn, Inc. ("Akorn" or the "Company" (NasdaqGS: AKRX) (CUSIP: 009728106). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
Why Akorn (AKRX) Is Down Today
at The Street - Mon Mar 03, 12:06PM CST
Akorn (AKRX) plunges after the generic pharmaceutical company issues first-quarter guidance that comes up short of analysts' expectations.
Stocks Edge Lower, Trade Mixed; Oil, Bonds, Dollar Rising
at Investor's Business Daily - Mon Mar 03, 9:33AM CST
Solid consumer spending and income numbers weren't enough to help stocks early Monday, as the major indexes skidded on Russia's military action in Ukraine. The Dow Jones industrial average fell 0.8% while the Nasdaq and the S&P 500 backed off 0.7%....
Akorn Q4 Meets But Guidance Disappoints, Stock Down
at Investor's Business Daily - Mon Mar 03, 9:07AM CST
Specialty drugmaker Akorn (AKRX) Monday reported a Q4 in line with estimates, but it guided 2014 below expectations and shares plummeted 15% in early trading in the stock market today. The company said profit totaled 14 cents a share, up a penny from...
Actavis to Acquire Four Products from Akorn
PR Newswire - Thu Apr 17, 3:15PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has entered into agreements with Akorn, Inc. and Hi-Tech Pharmacal Co. Inc. to purchase four currently marketed products and one product under development for cash consideration. The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech. Financial terms of the agreements were not disclosed.
Akorn Completes Acquisition of Hi-Tech Pharmacal
Business Wire - Thu Apr 17, 8:20AM CDT
Akorn, Inc. (NASDAQ: AKRX), a niche pharmaceutical company, announced today that it has completed its previously announced acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) for $640 million in cash. The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player. This combination also brings critical mass and scale to Akorn's business and strengthens the Company's position with retail and institutional customers.
Repligen Corporation Set to Join the S&P SmallCap 600
PR Newswire - Tue Apr 15, 4:53PM CDT
Repligen Corporation (NASD:RGEN) will replace Hi-Tech Pharmacal Co., Inc. (NASD:HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. S&P SmallCap 600 constituent Akorn Inc. (NASD:AKRX) is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.
Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition
Business Wire - Mon Apr 14, 6:00PM CDT
Akorn, Inc. (NASDAQ: AKRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to approve Akorn's acquisition of Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK). The unanimous vote in support of the transactions follows Akorn's agreement to a proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval. The parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by the end of this week.
Akorn, Inc. Announces First Quarter 2014 Earnings Release and Conference Call Information
PR Newswire - Thu Apr 10, 3:00PM CDT
Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, May 6, 2014, to discuss first quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Insider Trading Alert - BRCD, AKRX And CSOD Traded By Insiders
at The Street - Thu Mar 20, 10:00AM CDT
Stocks with insider trader activity include BRCD, AKRX and CSOD
Approvals, Financial Results, and Stock Movements - Analyst Notes on Merck, Novartis, Raptor, Akorn, and Pacira
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Novartis AG (NYSE: NVS), Raptor Pharmaceutical Corp. (NASDAQ: RPTP), Akorn, Inc. (NASDAQ: AKRX), and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Stocks on the Radar: Akorn, Central European Media Enterprises, Denny's, bebe stores, and Eni SpA
PR Newswire - Tue Mar 04, 9:25AM CST
The US markets ended on a negative sentiment on Monday, March 03, 2014, with the NASDAQ Composite closing at 4,277.30, down 0.72%; the Dow Jones Industrial Average ending the session at 16,168.03, down 0.94%, and S&P 500 edging 0.74% lower to close at 1,845.73. The losses were broad based with all ten sectors edging lower. Investor-Edge.com has initiated coverage on the following equities: Akorn Inc. (NASDAQ: AKRX), Central European Media Enterprises Ltd (NASDAQ: CETV), Denny's Corp. (NASDAQ: DENN), bebe stores inc. (NASDAQ: BEBE), and Eni SpA (NYSE: E) which witnessed unusually high trading volumes in the previous trading session. Free report on these five companies can be accessed at
Harwood Feffer LLP Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 8:00PM CST
NEW YORK, March 3, 2014 /PRNewswire/-- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against Akorn, Inc. ("Akorn" or the "Company"
(NASDAQ: AKRX) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws. Akorn's guidance disappoints
at Investor's Business Daily - Mon Mar 03, 5:36PM CST
The specialty drug maker's Q4 EPS rose 7.7% to 14 cents, in line with views. Sales rose 19% to $85 mil, above analysts' estimates for $83 mil. For all '13, sales rose 24% to $318 mil and net income climbed 6% to 55 cents a share. It guided '14 sales...
Akorn Guidance Worries Street As Strategy Hits Delays
at Investor's Business Daily - Mon Mar 03, 4:30PM CST
Specialty drugmaker Akorn's Q4 earnings met estimates Monday, but its 2014 guidance and a new accounting problem halted the IBD 50 stock dead in its tracks. Akorn (AKRX) said profit totaled 14 cents a share, up a penny from the year-earlier quarter...
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc.
PR Newswire - Mon Mar 03, 3:52PM CST
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Akorn, Inc. ("Akorn" or the "Company"
(NasdaqGS: AKRX). Such investors are advised to contact Peretz Bronstein or his investor Relation's coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484. Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 03, 12:34PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Stocks Down Hard But Up Slightly From Session Lows
at Investor's Business Daily - Mon Mar 03, 12:33PM CST
Stocks were off intraday lows but still down hard in afternoon trading as Russia's military action in Ukraine's Crimea region continued to stoke geopolitical fears. The Nasdaq was down 1.2%, the Dow 1.1% and the S&P 500 0.9%. Volume was mixed, with...
Why Akorn, Inc. Shares Were Cracked
Sean Williams, The Motley Fool - Motley Fool - Mon Mar 03, 12:22PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Akorn , a branded and generic developer of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX
PR Newswire - Mon Mar 03, 12:07PM CST
Pomerantz LLP is investigating claims on behalf of investors of Akorn, Inc. ("Akorn" or the "Company"
(NasdaqGS: AKRX) (CUSIP: 009728106). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. Why Akorn (AKRX) Is Down Today
at The Street - Mon Mar 03, 12:06PM CST
Akorn (AKRX) plunges after the generic pharmaceutical company issues first-quarter guidance that comes up short of analysts' expectations.
Stocks Edge Lower, Trade Mixed; Oil, Bonds, Dollar Rising
at Investor's Business Daily - Mon Mar 03, 9:33AM CST
Solid consumer spending and income numbers weren't enough to help stocks early Monday, as the major indexes skidded on Russia's military action in Ukraine. The Dow Jones industrial average fell 0.8% while the Nasdaq and the S&P 500 backed off 0.7%....
Akorn Q4 Meets But Guidance Disappoints, Stock Down
at Investor's Business Daily - Mon Mar 03, 9:07AM CST
Specialty drugmaker Akorn (AKRX) Monday reported a Q4 in line with estimates, but it guided 2014 below expectations and shares plummeted 15% in early trading in the stock market today. The company said profit totaled 14 cents a share, up a penny from...
